Machina Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Machina Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,831	Closed	-$443K	–	373
2023 Q3	$443K	Sell	3,831 -5,187	-58%	-$557K	0.25%	156
2023 Q2	$928K	Sell	9,018 -242	-3%	-$25.5K	0.53%	62
2023 Q1	$1.01M	Buy	+9,260	New	+$1.02M	0.89%	13
2022 Q3	–	Sell	-4,100	Closed	-$327K	–	200
2022 Q2	$327K	Buy	+4,100	New	+$388K	0.74%	64

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Machina Capital's HZNP Position: Q4 2023 in Review

Machina Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 3,831 shares — an estimated $443K sold.

Machina Capital first reported a position in HZNP in Q2 2022 and held it in 4 quarters. The position peaked at $1.01M in Q1 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Machina Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Machina Capital sold 3,831 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $443K.
Machina Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 4 quarters.
Machina Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.01M in Q1 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Machina Capital's 13F filing for Q4 2023, filed 6 Feb 2024.